384 results about "Fungal nail infection" patented technology

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.

A nail lacquer effective for the treatment or prevention of fungal infections, such as, onychomycosis, includes fungicidally effective amount of ciclopirox, econazole, or other antifungal agent in a clear, stable, film-forming lacquer vehicle which includes a water-insoluble film-forming polymer; 2-n-nonyl-1,3-dioxolane or similar penetration enhancer; and volatile solvent. A plasticizer for the film-forming polymer which is also compatible with the other components may be included although the preferred penetration enhancers may also function as plasticizer. The composition, when applied to the nails provides a hard, clear, water-resistant film containing the antifungal agent. The film is resistant to multiple washings and is effective in the treatment of onychomycosis.

A nail lacquer for the treatment or prevention of fungal infections, such as, onychomycosis, includes fungicidally effective amount of ciclopirox, econazole, or other antifungal agent in a compatible film-forming lacquer vehicle which includes a water-insoluble film-forming polymer; pentadecalactone, or similar cyclic lactone compound or derivative thereof, and volatile solvent. The pentadecalactone functions as a plasticizer for the film-forming polymer and as a penetration enhancer for the antifungal agent. The composition, when applied to the nails provides a hard, clear, water-resistant film containing the antifungal agent. The compositions are used for the treatment of onychomycosis.

Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a pharmaceutically acceptable base in a formulation having a pH of 7.5 to about 13.0, preferably about 8.0 to 11.5, and most preferably about 8.5 to 10.5. These basic formulations permeate the nail and are effective in treating fungal infections of the nail and surrounding tissues.

A device is provided that allows for target treatment of infections, caused by dermatophytes, yeast fungus, and mould fungus, such as onychomycosis and dermatophytosis. The device comprises a nitric oxide (NO) eluting polymer arranged to contact the infected area, such that a therapeutic dose of nitric oxide is eluted from said nitric oxide eluting polymer to said area. The nitric oxide (NO) eluting polymer is integrated with a carrier material, such that said carrier material, in use, regulates and controls the elution of said therapeutic dosage of nitric oxide (NO). Furthermore, a corresponding manufacturing method is provided.

A method of treatment of onychomychosis wherein a hydrogel is supersaturated with an antimycotic agent and supported on a backing. The assembly is placed over an infected nail for an extended period of time. The antimycotic agent diffuses through the nail to the underlying infection.

The present invention relates to methods and devices for treating hard biological tissue (in particular, keratin-rich hard tissues) with electromagnetic energy having a frequency of at least 0.5 MHZ (megahertz) and less than 10 GHZ (gigahertz) (for example, HF, RF or microwave energy), and particularly, to methods aid devices for treating infections, for example, fungal infections of the nail.

A dual action antifungal nail coat composition and method of use for ameliorating or preventing fungal infection of the nails, and onychomycosis, in particular, is disclosed. Composition embodiments in the form of one-coat type and two-coat type suitable for daily fungicidal regimens are disclosed. A preferred antifungal nail coat composition comprises an effective fungicidal amount of antifungal agent, a permeation enhancing amount of a substantially non-volatile, permeation enhancer, a film-forming amount of a hydrophilic polymer, and a pharmaceutically acceptable, volatile carrier. The composition provides a substantially water-soluble fungicidal coating on contacting a fungally susceptible or infected nail.

Provided herein are compositions and formulations comprising an antifungal agent. Pharmaceutical compositions comprising luliconazole in an amount effective for the treatment of onychomycosis are provided. Also provided are methods for treating dermatomycoses and onychomycosis using the compositions and formulations.

The invention discloses a multifunctional comprehensive treatment platform, comprising a main machine (1), an articulated arm (2) and a treatment head (3), wherein one end of the articulated arm (2) is connected with the top of the main machine (1), the other end of the articulated arm (2) is provided with the treatment head (3), and the treatment head (3) is a UVB (ultraviolet b) treatment head, or a UVA1 (ultraviolet a1) treatment head, or a high-energy red light treatment head, or an integrated optical source treatment head, or an onychomycosis treatment module or a laser anti-obesity treatment head. The platform uses a rotation fixing device to install and fix different treatment heads with various purposes and has the advantages that on one hand, the disassembly and the assembly are convenient, the connection is reliable, and the replacing is convenient and fast; and on the other hand, the function that one main machine can be equipped with various treatment heads with different functions, the treatment field is wide, a great deal of space is saved for the placement of equipment, and the cost of a hospital or a beauty institution is greatly reduced.

The invention relates to the field of pharmaceutical formulation, and particularly to a traditional Chinese medicine decoction for treating onychomycosis as well as tinea manus and pedis. The traditional Chinese medicine decoction is characterized by comprising raw medical materials in parts by weight of: 25-35 parts of cortex pseudolaricis, 20-30 parts of common cnidium fruit, 15-30 parts of sessile stemona root, 10-20 parts of lilac, 25-35 parts of cotex dictamni, 10-15 parts of garden balsam stem, 15-25 parts of paniculate swallowwort root, 15-20 parts of baical skullcap root, 20-35 parts of radix sophorae flavescentis, 15-25 parts of dried alum, 15-20 parts of alum, 20-30 parts of gallnut, 15-25 parts of belvedere fruit, 15-25 parts of Chinese rhubarb, 15-25 parts of Japanese knotweed, 20-25 parts of chaulmoogratree seeds, 15-25 parts of capsicum annuum, 20-25 parts of golden cypress and 15-25 parts of garlic, wherein the 19 raw medical materials above after being mixed are soaked in water; and slag is removed after the mixture is decocted to obtain filter liquor. The traditional Chinese medicine decoction is used for treating the onychomycosis as well as the tinea manus and pedis, has good curative effects, is convenient to use and can eradicate the onychomycosis as well as the tinea manus and pedis thoroughly without recrudescence and side effect.

A portable, small-footprint laser device contains one or more housings in which a laser energy source and an optical arrangement are disposed. The housing produces a laser beam spot that may be rotated and scanned to apply laser energy to a target area. The laser device receives treatment parameters and uses them to program a treatment regimen in which activation and movement of the housings is automated. The laser device may be used to apply a treatment regimen to a patient's hands or feet that are infected by Onychomycosis. In the treatment regimen, certain wavelengths of laser energy are applied at a predetermined duration. The treatment may be repeated, and a topical anti-fungal medication may be applied to aid in the efficacy of the treatment.

The present invention relates to a pharmaceutical formulation comprising a pharmaceutically activeagent; water; a polyethylene glycol or a poloxamer; and a polyethylene glycol mono- or di-ether. Preferably the pharmaceutically active agent is an anti-fungal or anti-mycotic agent. Preferably the pharmaceutically active agent is lipophilic and/or keratinophilic. The present invention also relates to the use of the formulation in treating diseases, disorders or pathological conditions of the nail or skin, such as onychomycosis, dermatomycosis and other mycoses. The present invention also relates to a method of administering a pharmaceutically active agent to a subject by applying the formulation comprising the pharmaceutically active agent to a nail or skin of the subject. The present invention further relates to a method of preparing the formulation.

The invention discloses a drug used for curing tinea of feet and hands and tinea unguium, and the drug is prepared by fructus bruceae, cortex pseudolaricis, radix stemonae,cortex dictamni and radices sophorae flavescentis which are ground to powder and are put in a gauze bag which is then soaked in glacial acetic acid with the concentration of 30 percent or 30-degree vinegar essence for one week; and then the obtained mixture is filtered, sterilized and bottled so as to obtain the drug. By virtue of the compatibility of the raw materials, the drug used for curing the tinea of feet and hands and the tinea unguium of the invention has the functions of clearing away heat and toxic materials, drying and eliminating dampness, killing parasites to relieve itching, diminishing inflammation, resisting and killing eumycetes and softening and moistening and has obvious effect on killing the eumycetes caused by the tinea of feet and hands and onychomycosis. The drug of the invention utilizes pure natural Chinese medical herbs to treat the tinea of feet and hands and the tinea unguium, thus avoiding damage caused by taking orally to liver and kidney, and having convenient use, instant effect and short course of treatment and no recrudescence after the treatment. The drug of the invention also has good effect on curing scald head and psoriasis.